Xenon Pharmaceuticals, Inc. (XENE)
60.54
-0.23
(-0.38%)
USD |
NASDAQ |
Aug 24, 16:00
60.54
0.00 (0.00%)
After-Hours: 20:00
Xenon Pharmaceuticals Total Assets (Quarterly) : 1.296B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.296B |
| March 31, 2026 | 1.387B |
| December 31, 2025 | 981.67M |
| September 30, 2025 | 607.84M |
| June 30, 2025 | 674.28M |
| March 31, 2025 | 743.28M |
| December 31, 2024 | 1.067B |
| September 30, 2024 | 835.90M |
| June 30, 2024 | 884.01M |
| March 31, 2024 | 919.02M |
| December 31, 2023 | 964.80M |
| September 30, 2023 | 671.09M |
| June 30, 2023 | 684.90M |
| March 31, 2023 | 719.87M |
| December 31, 2022 | 754.15M |
| September 30, 2022 | 775.81M |
| June 30, 2022 | 807.38M |
| March 31, 2022 | 558.06M |
| December 31, 2021 | 572.01M |
| September 30, 2021 | 264.35M |
| June 30, 2021 | 274.71M |
| March 31, 2021 | 290.67M |
| December 31, 2020 | 189.19M |
| September 30, 2020 | 199.13M |
| June 30, 2020 | 210.68M |
| Date | Value |
|---|---|
| March 31, 2020 | 237.04M |
| December 31, 2019 | 147.70M |
| September 30, 2019 | 98.90M |
| June 30, 2019 | 105.89M |
| March 31, 2019 | 114.55M |
| December 31, 2018 | 122.43M |
| September 30, 2018 | 130.46M |
| June 30, 2018 | 65.44M |
| March 31, 2018 | 37.76M |
| December 31, 2017 | 46.12M |
| September 30, 2017 | 46.36M |
| June 30, 2017 | 54.23M |
| March 31, 2017 | 60.79M |
| December 31, 2016 | 67.49M |
| September 30, 2016 | 73.37M |
| June 30, 2016 | 55.69M |
| March 31, 2016 | 61.15M |
| December 31, 2015 | 63.95M |
| September 30, 2015 | 69.94M |
| June 30, 2015 | 76.53M |
| March 31, 2015 | 79.40M |
| December 31, 2014 | 87.42M |
| September 30, 2014 | 54.14M |
| June 30, 2014 | 50.71M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Sirona Biochem Corp. | -- |
| Psyence Biomedical Ltd. | 12.81M |
| Aurinia Pharmaceuticals, Inc. | 792.26M |
| enGene Therapeutics, Inc. | 307.52M |
| Medicus Pharma Ltd. | 19.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 53.38M |
| Shareholders Equity (Quarterly) | 1.242B |
| Debt to Equity Ratio | 0.0052 |
| Current Ratio | 21.02 |
| Net Debt Paydown Yield | 0.01% |